Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Pgf1
2. Pgf1 Alpha
3. Pgf1alpha
4. Prostaglandin F1
5. Prostaglandin F1, (8beta,9alpha,11alpha,13e,15s)-isomer
6. Prostaglandin F1, (9alpha,11alpha,13e,15r)-isomer
7. Prostaglandin F1, (9alpha,11alpha,13e,15s)-(+-)-isomer
8. Prostaglandin F1, (9alpha,11beta,13e,15s)-isomer
1. Prostaglandin F1
2. 745-62-0
3. Pgf1alpha
4. Pgf 1-alpha
5. Prostaglandin F1-alpha
6. Prostaglandin F1.alpha.
7. Mls000069612
8. 9s,11r,15s-trihydroxy-13e-prostaenoic Acid
9. Chebi:28852
10. Prostaglandin F1a
11. Wj72o6860w
12. 7-[(1r,2r,3r,5s)-3,5-dihydroxy-2-[(e,3s)-3-hydroxyoct-1-enyl]cyclopentyl]heptanoic Acid
13. Smr000058791
14. Cyclopentaneheptanoic Acid, 3,5-dihydroxy-2-(3-hydroxy-1-octenyl)-
15. Prost-13-en-1-oic Acid,9,11,15-trihydroxy-, (9a,11a,13e,15s)-
16. Protaglandin F1
17. Prostaglandin F1
18. A
19. Prostaglandin F1 Alpha
20. Pgf1
21. Unii-wj72o6860w
22. Opera_id_1669
23. U 18714
24. Bspbio_001492
25. Bml1-f09
26. Gtpl5412
27. Schembl1477281
28. Chembl1325783
29. Prostaglandin F1alpha, Synthetic
30. Dtxsid901339475
31. Hms1361k14
32. Hms1791k14
33. Hms1989k14
34. Hms2231h22
35. Hms3402k14
36. Hms3648j19
37. Zinc4097164
38. Lmfa03010137
39. (9alpha,11alpha,13e,15s)-9,11,15-trihydroxyprost-13-en-1-oic Acid
40. Idi1_033962
41. Pgf1 Alpha (prostaglandin F1 Alpha )
42. Prost-13-en-1-oic Acid, 9,11,15-trihydroxy-, (9-alpha,11-alpha,13e,15s)
43. Ncgc00021875-03
44. Ncgc00021875-04
45. Ncgc00021875-05
46. Pgf1alpha, Prostaglandin F1alpha, Powder
47. C06475
48. 9a,11a,15(s)-trihydroxy-13-trans-prostenoate
49. Sr-01000946441
50. 9a,11a,15(s)-trihydroxy-13-trans-prostenoic Acid
51. Sr-01000946441-1
52. Q27088352
53. (13e,15s)-9alpha,11alpha,15-trihydroxyprost-13-en-1-oic Acid
54. (+)-(9alpha,11alpha,13e,15s)-9,11,15-trihydroxyprost-13-en-1-oic Acid
55. (13e,15s)-9alpha,11alpha-9,11,15-trihydroxyprost-13-en-1-oic Acid
56. 3,5-dihydroxy-2-(3-hydroxy-1-octenyl)- (8ci)-cyclopentaneheptanoate
57. 3,5-dihydroxy-2-(3-hydroxy-1-octenyl)- (8ci)-cyclopentaneheptanoic Acid
58. Prost-13-en-1-oic Acid,9,11,15-trihydroxy-,(9a,11a,13e,15s)-
59. 7-((1r,2r,3r,5s)-3,5-dihydroxy-2-((s,e)-3-hydroxyoct-1-enyl)cyclopentyl)heptanoic Acid
60. Prost-13-en-1-oic Acid, 9,11,15-trihydroxy-, (9-.alpha.,11-.alpha.,13e,15s)
61. 7-[(1r,2r,3r,5s)-3,5-dihydroxy-2-[(1e,3s)-3-hydroxyoct-1-en-1-yl]cyclopentyl]heptanoic Acid
| Molecular Weight | 356.5 g/mol |
|---|---|
| Molecular Formula | C20H36O5 |
| XLogP3 | 3.5 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 13 |
| Exact Mass | 356.25627424 g/mol |
| Monoisotopic Mass | 356.25627424 g/mol |
| Topological Polar Surface Area | 98 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 396 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
22
PharmaCompass offers a list of Prostaglandin F1 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Prostaglandin F1 manufacturer or Prostaglandin F1 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Prostaglandin F1 manufacturer or Prostaglandin F1 supplier.
PharmaCompass also assists you with knowing the Prostaglandin F1 API Price utilized in the formulation of products. Prostaglandin F1 API Price is not always fixed or binding as the Prostaglandin F1 Price is obtained through a variety of data sources. The Prostaglandin F1 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Prostaglandin F1 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Prostaglandin F1, including repackagers and relabelers. The FDA regulates Prostaglandin F1 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Prostaglandin F1 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Prostaglandin F1 supplier is an individual or a company that provides Prostaglandin F1 active pharmaceutical ingredient (API) or Prostaglandin F1 finished formulations upon request. The Prostaglandin F1 suppliers may include Prostaglandin F1 API manufacturers, exporters, distributors and traders.
Prostaglandin F1 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Prostaglandin F1 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Prostaglandin F1 GMP manufacturer or Prostaglandin F1 GMP API supplier for your needs.
A Prostaglandin F1 CoA (Certificate of Analysis) is a formal document that attests to Prostaglandin F1's compliance with Prostaglandin F1 specifications and serves as a tool for batch-level quality control.
Prostaglandin F1 CoA mostly includes findings from lab analyses of a specific batch. For each Prostaglandin F1 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Prostaglandin F1 may be tested according to a variety of international standards, such as European Pharmacopoeia (Prostaglandin F1 EP), Prostaglandin F1 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Prostaglandin F1 USP).
